Location History:
- München, DE (2018 - 2020)
- Munich, DE (2019 - 2022)
Company Filing History:
6 out of 75 
3 out of 155 
2 out of 132 
Years Active: 2018-2022
Title: Innovations in Hepatitis B Treatment: The Contributions of Ulrike Protzer
Introduction: Ulrike Protzer is a prominent inventor based in Munich, Germany, known for her groundbreaking work in the field of virology and biotechnology. With a total of seven patents to her name, she has significantly advanced methods for treating and preventing Hepatitis B virus (HBV) infections, contributing to the ongoing battle against viral diseases.
Latest Patents: Among her latest patents, one notable invention focuses on providing methods for the treatment of subjects with HBV infections. This innovative approach combines an RNA interference (RNAi) agent targeting HBV with an effective vaccine. The invention outlines a sequential administration regimen that involves an RNAi agent inhibiting the expression of HBV transcripts, alongside a protein-based vaccine containing HBV core and surface antigens and a nucleic acid-based vaccine designed for enhanced immunogenicity.
Another significant patent involves improved recombinant vaccination vectors that can be utilized for treating or vaccinating against HBV. This includes pharmaceutical compositions or vaccines comprising the recombinant vector, showcasing her dedication to enhancing the efficacy of Hepatitis B treatments.
Career Highlights: Ulrike Protzer's impressive career includes vital positions at esteemed research institutions, such as the German Cancer Research Center (Deutsches Krebsforschungszentrum) and the Technical University of Munich (Technische Universität München). Her extensive work in these organizations has allowed her to remain at the forefront of hepatitis research and innovation.
Collaborations: Throughout her career, Protzer has collaborated with various notable individuals, including her colleagues Felix Bohne and Frank Momburg. These partnerships have enabled her to develop and refine innovative techniques and products aimed at fighting influenza and other viral infections.
Conclusion: Ulrike Protzer's contributions to the field of virology showcase her exemplary skills as an inventor and researcher. Through her patents and collaborative efforts, she continues to pave the way for effective treatment strategies for Hepatitis B, highlighting the importance of innovation in the medical field. Her work not only represents a significant advancement in the science of viral infections but also underscores the impact of dedicated researchers in improving global health outcomes.